angiotensin ii has been researched along with cyc 202 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
Han, M; Li, AY; Wen, JK; Zheng, B | 1 |
Busk, PK; Hansen, AH; Haunsø, S; Hinrichsen, R | 1 |
3 other study(ies) available for angiotensin ii and cyc 202
Article | Year |
---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
Roscovitine inhibits ERK1/2 activation induced by angiotensin II in vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Base Sequence; Cells, Cultured; Chromatin Immunoprecipitation; DNA Primers; Enzyme Activation; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Phosphorylation; Protein Kinase Inhibitors; Purines; Rats; Rats, Sprague-Dawley; Roscovitine | 2008 |
Phosphorylation of pRb by cyclin D kinase is necessary for development of cardiac hypertrophy.
Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cell Proliferation; Cells, Cultured; Cyclin D; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cyclins; DNA; DNA Replication; E2F Transcription Factors; Hexanones; Myocytes, Cardiac; Phosphorylation; Protein Biosynthesis; Purines; Rats; Rats, Wistar; Retinoblastoma Protein; Roscovitine; Up-Regulation | 2008 |